# High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid

> **NCT03156907** · PHASE2 · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 60 (estimated)

## Conditions studied

- High Dosage Buprenorphine

## Interventions

- **DRUG:** Buprenorphine

## Key facts

- **NCT ID:** NCT03156907
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-15
- **Primary completion:** 2024-12
- **Final completion:** 2025-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03156907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03156907, "High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03156907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*